Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures
- PMID: 34784910
- PMCID: PMC8597210
- DOI: 10.1186/s12891-021-04845-x
Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures
Abstract
Introduction: New vertebral compression fractures (NVCFs) are adverse events after vertebral augmentation of osteoporotic vertebral compression fractures (OVCFs). Predicting the risk of vertebral compression fractures (VCFs) accurately after surgery is still a significant challenge for spinal surgeons. The aim of our study was to identify risk factors of NCVFs after vertebral augmentation of OVCFs and develop a nomogram.
Methods: We retrospectively reviewed the medical records of patients with OVCFs who underwent percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP). Patients were divided into the NVCFs group and control group, base on the patients with or without NVCFs within 2 years follow-up period after surgery. A training cohort of 403 patients diagnosed in our hospital from June 2014 to December 2016 was used for model development. The independent predictive factors of postoperative VCFs were determined by least absolute shrinkage and selection operator (LASSO) logistic regression, univariate analysis and multivariate logistic regression analysis. We provided a nomogram for predicting the risk of NVCFs based on independent predictive factors and used the receiver operating characteristic curve (ROC), calibration curve, and decision curve analyses (DCA) to evaluated the prognostic performance. After internal validation, the nomogram was further evaluated in a validation cohort of 159 patients included between January 2017 and June 2018.
Results: Of the 403 patients in the training cohort, 49(12.16%) were NVCFs at an average of 16.7 (1 to 23) months within the 2 years follow-up period. Of the 159 patients in the validation cohort, 17(10.69%) were NVCFs at an average of 8.7 (1 to 15) months within the 2 years follow-up period. In the training cohort, the proportions of elderly patients older than 80 years were 32.65 and 13.56% in the NVCFs and control group, respectively (p = 0.003). The percentages of patients with previous fracture history were 26.53 and 12.71% in the NVCFs and control group, respectively (p = 0.010). The volume of bone cement were 4.43 ± 0.88 mL and 4.02 ± 1.13 mL in the NVCFs and Control group, respectively (p = 0.014). The differences have statistical significance in the bone cement leakage, bone cement dispersion, contact with endplate, anti-osteoporotic treatment, post-op Cobb angle and Cobb angle restoration characteristics between the two groups. The model was established by multivariate logistic regression analysis to obtain independent predictors. In the training and validation cohort, the AUC of the nomogram were 0.882 (95% confidence interval (CI), 0.824-0.940) and 0.869 (95% CI: 0.811-0.927), respectively. The C index of the nomogram was 0.886 in the training cohort and 0.893 in the validation cohort, demonstrating good discrimination. In the training and validation cohort, the optimal calibration curves demonstrated the coincidence between prediction and actual status, and the decision curve analysis demonstrated that the full model had the highest clinical net benefit across the entire range of threshold probabilities.
Conclusion: A nomogram for predicting NVCFs after vertebral augmentation was established and validated. For patients evaluated by this model with predictive high risk of developing postoperative VCFs, postoperative management strategies such as enhance osteoporosis-related health education and management should be considered.
Keywords: New vertebral compression fractures; Nomogram; Osteoporosis vertebral compression fractures; Percutaneous kyphoplasty; Percutaneous vertebroplasty; Vertebral augmentation.
© 2021. The Author(s).
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
Development and validation of a nomogram for predicting new vertebral compression fractures after percutaneous kyphoplasty in postmenopausal patients.J Orthop Surg Res. 2023 Nov 30;18(1):914. doi: 10.1186/s13018-023-04400-5. J Orthop Surg Res. 2023. PMID: 38037128 Free PMC article.
-
Establishment and validation of a nomogram for predicting new fractures after PKP treatment of for osteoporotic vertebral compression fractures in the elderly individuals.BMC Musculoskelet Disord. 2023 Sep 12;24(1):728. doi: 10.1186/s12891-023-06801-3. BMC Musculoskelet Disord. 2023. PMID: 37700293 Free PMC article.
-
Risk factors for recollapse of new vertebral compression fractures after percutaneous kyphoplasty in geriatric patients: establishment of a nomogram.BMC Musculoskelet Disord. 2022 May 14;23(1):458. doi: 10.1186/s12891-022-05409-3. BMC Musculoskelet Disord. 2022. PMID: 35568857 Free PMC article.
-
Establishment and validation of a nomogram and web calculator for the risk of new vertebral compression fractures and cement leakage after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures.Eur Spine J. 2022 May;31(5):1108-1121. doi: 10.1007/s00586-021-07064-z. Epub 2021 Nov 25. Eur Spine J. 2022. PMID: 34822018 Review.
-
Does Percutaneous Vertebroplasty or Balloon Kyphoplasty for Osteoporotic Vertebral Compression Fractures Increase the Incidence of New Vertebral Fractures? A Meta-Analysis.Pain Physician. 2017 Jan-Feb;20(1):E13-E28. Pain Physician. 2017. PMID: 28072794 Review.
Cited by
-
Risk factors of new vertebral compression fracture after percutaneous vertebroplasty or percutaneous kyphoplasty.Front Endocrinol (Lausanne). 2022 Aug 31;13:964578. doi: 10.3389/fendo.2022.964578. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120447 Free PMC article.
-
Establishing a nomogram to predict refracture after percutaneous kyphoplasty by logistic regression.Front Neuroinform. 2023 Dec 21;17:1304248. doi: 10.3389/fninf.2023.1304248. eCollection 2023. Front Neuroinform. 2023. PMID: 38187823 Free PMC article.
-
Risk factors for subsequent vertebral fractures after percutaneous vertebral augmentation in Asian populations: a systematic review and meta-analysis.BMC Musculoskelet Disord. 2025 Aug 16;26(1):791. doi: 10.1186/s12891-025-08998-x. BMC Musculoskelet Disord. 2025. PMID: 40819163 Free PMC article.
-
Development and validation of a nomogram for predicting new vertebral compression fractures after percutaneous kyphoplasty in postmenopausal patients.J Orthop Surg Res. 2023 Nov 30;18(1):914. doi: 10.1186/s13018-023-04400-5. J Orthop Surg Res. 2023. PMID: 38037128 Free PMC article.
-
Establishment and Verification of a Predictive Nomogram for New Vertebral Compression Fracture Occurring after Bone Cement Injection in Middle-Aged and Elderly Patients with Vertebral Compression Fracture.Orthop Surg. 2023 Apr;15(4):961-972. doi: 10.1111/os.13655. Epub 2023 Jan 31. Orthop Surg. 2023. PMID: 36718651 Free PMC article.
References
-
- Firanescu CE, de Vries J, Lodder P, Venmans A, Schoemaker MC, Smeets AJ, Donga E, Juttmann JR, Klazen C, Elgersma O, et al. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ. 2018;361:k1551. doi: 10.1136/bmj.k1551. - DOI - PMC - PubMed
-
- Svensson HK, Olsson LE, Hansson T, Karlsson J, Hansson-Olofsson E. The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures-a systematic review of the literature. Osteoporos Int. 2017;28(9):2521–2540. doi: 10.1007/s00198-017-4099-8. - DOI - PMC - PubMed
-
- Xu JC, Wu GH, Zhou LL, Yang XJ, Liu JT. Two unilateral puncturation comparative analyses of multiple-level fresh osteoporotic vertebral body compression fractures treated with percutaneous vertebroplasty guided by C-arm fluoroscopy or in senile patients. Eur Rev Med Pharmacol Sci. 2017;21(7):1456–1461. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous